Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

Detachin™ Cell Detachment Solution from AMSBIO is a high-performance alternative to Trypsin/EDTA for detaching adherent cells from in vitro growth vessels.

In tandem, the company expands into Europe through partnerships with leading research and medical institutions to help them predict and prevent cancer relapse.

Eppendorf Xplorer plus can now tackle entire columns and rows of a 384-well plate in one single step.

This groundbreaking new approach offers quality controlled, sequencing-ready NGS libraries in just a matter of hours.

Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells.

Recognizing the escalating incidence of lung cancer in China, Owlstone Medical and Renji Hospital have a mutual interest in developing and making accessible diagnostics for the early detection of disease.

Porvair Sciences reports on its involvement in a new £2.6 million project.

Companies announce a strategic partnership to accelerate Pathios’ drug discovery and development programmes.

These award-winning solutions provide scientists across a range of fields and disciplines with the ability to conduct comprehensive proteome profiling and quantitation, biomarker discovery and verification, and the full characterization of complex biotherapeutics.